Skip to main content
Top
Published in: Cancer Causes & Control 11/2014

01-11-2014 | Original paper

Italianity is associated with lower risk of prostate cancer mortality in Switzerland

Authors: Aline Richard, David Faeh, Sabine Rohrmann, Julia Braun, Silvan Tarnutzer, Matthias Bopp

Published in: Cancer Causes & Control | Issue 11/2014

Login to get access

Abstract

Purpose

Different prostate cancer mortality rates observed in European countries may depend on cultural background. We aimed at exploring variation in prostate cancer mortality in the language regions of Switzerland as a function of “Italianity”, a proxy for adherence to an Italian lifestyle.

Methods

We used data of the Swiss National Cohort, a census-based record linkage study, consisting of census (1990 and 2000) and mortality (until 2008) data. 1,163,271 Swiss and Italian nationals 40+-year old were included. Multivariate age-standardized prostate cancer mortality rates and hazard ratios (HR) from Cox proportional hazards regression analysis were performed. Italianity was defined by an individual’s nationality, place of birth and principal language, resulting in a score of 0–3 points.

Results

Age-standardized prostate cancer mortality rates (per 100,000 person-years) were lowest in the Italian-speaking region of Switzerland (66.7 vs. 87.3 in the German-speaking region). Both Italian nationality and/or place of birth were significantly associated with lower mortality. There was a graded inverse association between mortality rates and increasing Italianity score. Individuals with the highest level of Italianity had a HR of 0.67 (95 % CI 0.59–0.76) compared to those with an Italianity score of zero. Results were similar when looking at language regions separately.

Conclusions

The strong and consistent association between Italianity and prostate cancer mortality suggests protective properties of an Italian lifestyle. Further research is required in order to determine which factors specific for Italian culture are responsible for the lower prostate cancer mortality.
Literature
3.
9.
go back to reference Dehler S, Rohrmann S, Lorez M, Clough-Gorr K (2013) Trends in prostate cancer survival in Switzerland. Schweiz Krebsbulletin 1:54–58 Dehler S, Rohrmann S, Lorez M, Clough-Gorr K (2013) Trends in prostate cancer survival in Switzerland. Schweiz Krebsbulletin 1:54–58
11.
go back to reference Bundesamt für Statistik (2005) Eidgenössische Volkszählung 2000. Abschlussbericht zur Volkszählung 2000. Neuchâtel Bundesamt für Statistik (2005) Eidgenössische Volkszählung 2000. Abschlussbericht zur Volkszählung 2000. Neuchâtel
12.
go back to reference Bopp M, Spoerri A, Zwahlen M, Gutzwiller F, Paccaud F, Braun-Fahrlander C, Rougemont A, Egger M (2009) Cohort profile: the Swiss National Cohort—a longitudinal study of 6.8 million people. Int J Epidemiol 38(2):379–384. doi:10.1093/ije/dyn042 PubMedCrossRef Bopp M, Spoerri A, Zwahlen M, Gutzwiller F, Paccaud F, Braun-Fahrlander C, Rougemont A, Egger M (2009) Cohort profile: the Swiss National Cohort—a longitudinal study of 6.8 million people. Int J Epidemiol 38(2):379–384. doi:10.​1093/​ije/​dyn042 PubMedCrossRef
14.
go back to reference Swiss Federal Statistical Office (1979) Statistisches Jahrbuch der Schweiz 1979. Birkhäuser Verlag, Basel Swiss Federal Statistical Office (1979) Statistisches Jahrbuch der Schweiz 1979. Birkhäuser Verlag, Basel
15.
18.
go back to reference Khlat M, Darmon N (2003) Is there a Mediterranean migrants mortality paradox in Europe? Int J Epidemiol 32(6):1115–1118PubMedCrossRef Khlat M, Darmon N (2003) Is there a Mediterranean migrants mortality paradox in Europe? Int J Epidemiol 32(6):1115–1118PubMedCrossRef
19.
go back to reference Geddes M, Balzi D, Buiatti E, Brancker A, Parkin DM (1994) Cancer mortality in Italian migrants to Canada. Tumori 80(1):19–23PubMed Geddes M, Balzi D, Buiatti E, Brancker A, Parkin DM (1994) Cancer mortality in Italian migrants to Canada. Tumori 80(1):19–23PubMed
20.
go back to reference Geddes M, Parkin D, Khlat M, Balzi D, Buiatti E (1993) Cancer in Italian migrant populations. IARC, Lyon Geddes M, Parkin D, Khlat M, Balzi D, Buiatti E (1993) Cancer in Italian migrant populations. IARC, Lyon
21.
go back to reference Bundesamt für Statistik (2011) Krebs in der Schweiz. Stand und Entwicklung von 1983-2007. Neuchâtel Bundesamt für Statistik (2011) Krebs in der Schweiz. Stand und Entwicklung von 1983-2007. Neuchâtel
24.
go back to reference World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington, DC World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington, DC
26.
go back to reference von Karstedt L (2004) Sprache und Kultur - Eine Geschichte der deutschsprachigen Ethnolinguistik. Universität Hamburg, Hamburg von Karstedt L (2004) Sprache und Kultur - Eine Geschichte der deutschsprachigen Ethnolinguistik. Universität Hamburg, Hamburg
28.
go back to reference Lutz JM, Pury P, Fioretta G, Raymond L (2004) The impact of coding process on observed cancer mortality trends in Switzerland. Eur J Cancer Prev 13(1):77–81PubMedCrossRef Lutz JM, Pury P, Fioretta G, Raymond L (2004) The impact of coding process on observed cancer mortality trends in Switzerland. Eur J Cancer Prev 13(1):77–81PubMedCrossRef
30.
Metadata
Title
Italianity is associated with lower risk of prostate cancer mortality in Switzerland
Authors
Aline Richard
David Faeh
Sabine Rohrmann
Julia Braun
Silvan Tarnutzer
Matthias Bopp
Publication date
01-11-2014
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 11/2014
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-014-0456-5

Other articles of this Issue 11/2014

Cancer Causes & Control 11/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine